Insights on the Auto-Injectors Global Market to 2026 - Featuring Antares Pharma, Mylan & Amgen Among Others
October 01, 2020 04:59 ET
|
Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Auto-Injectors Market Global Forecast by Regions, Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types,...
AB Science dévoile les résultats de son étude de Phase IIB/III dans les formes progressives de la Sclérose en Plaques à l’occasion du plus grand congrès international sur la sclérose en plaques
September 14, 2020 00:58 ET
|
AB Science
Paris, 14 septembre 2020, 7h00 Communiqué de Presse AB Science dévoile les résultats de son étude de Phase IIB/III dans les formes progressives de la Sclérose en Plaques à l’occasion du plus grand...
AB Science Presents Phase 2B/3 Study Results in Progressive Multiple Sclerosis at the World's Largest Multiple Sclerosis Research Conference
September 14, 2020 00:58 ET
|
AB Science
Paris, September 14, 2020, 7am Press release AB Science Presents Phase 2B/3 Study Results in Progressive Multiple Sclerosis at the World's Largest Multiple Sclerosis Research Conference 50% of...
AB Science présentera les résultats de son étude de phase 2B/3 AB07002 dans les formes progressives de la sclérose en plaques à la 8ème réunion conjointe ACTRIMS-ECTRIMS (MSVirtual2020)
September 07, 2020 01:30 ET
|
AB Science
Paris, 7 septembre 2020, 7h30 AB Science présentera les résultats de son étude de phase 2B/3 AB07002dans les formes progressives de la sclérose en plaques à la 8ème réunion conjointe ACTRIMS-ECTRIMS...
AB Science to present results from its Phase 2B/3 AB07002 study in progressive forms of multiple sclerosis at MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting
September 07, 2020 01:30 ET
|
AB Science
Paris, September 07, 2020, 7.30am AB Science to present results from its Phase 2B/3 AB07002 study in progressive forms of multiple sclerosis at MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting ...
AB Science annonce que de nouveaux résultats publiés dans la revue médicale évaluée par des pairs Journal of Alzheimer’s Disease renforcent la plausibilité du mode d’action du masitinib dans la maladie d’Alzheimer
July 08, 2020 02:57 ET
|
AB Science
Paris, 8 juillet 2020, 9h De nouveaux résultats publiés dans la revue médicale évaluée par des pairsJournal of Alzheimer’s Disease renforcent la plausibilité du mode d’actiondu masitinib dans...
AB Science announces that new results published in the peer-reviewed Journal of Alzheimer's Disease support masitinib’s potential mode of action in Alzheimer’s Disease
July 08, 2020 02:57 ET
|
AB Science
Paris, 08 July 2020, 9am New results published in the peer-reviewed Journal of Alzheimer's Diseasesupport masitinib’s potential mode of action in Alzheimer’s Disease ...
Surrey Neuroplasticity Clinic restarts PoNS Treatment™ for gait deficit due to multiple sclerosis
June 01, 2020 09:00 ET
|
Spotlight West Communications Inc.
SURREY, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) -- The Surrey Neuroplasticity Clinic is pleased to announce that it will recommence the use of the Portable Neuromodulation Stimulator...
Telehealth Cognitive Rehabilitation Can Be Effective for Multiple Sclerosis
May 11, 2020 08:00 ET
|
Posit Science
SAN FRANCISCO, May 11, 2020 (GLOBE NEWSWIRE) -- An independent review of the scientific literature found that certain telehealth rehabilitation treatments can be effective in addressing cognitive...
AB Science is hosting live webcast on Monday May 11, 2020 on masitinib in combination with isoquercetine for the treatment of COVID-19
May 07, 2020 13:16 ET
|
AB Science
Paris, May 07, 2020, 7pm AB Science is hosting live webcast on Monday May 11, 2020 on masitinibin combination with isoquercetine for the treatment of COVID-19 AB Science SA (NYSE Euronext -...